about
Role of 18F-FDG PET/CT in the carcinoma of the uterus: a review of literatureHow We Read Oncologic FDG PET/CTHigh clinical and morphologic response using 90Y-DOTA-octreotate sequenced with 177Lu-DOTA-octreotate induction peptide receptor chemoradionuclide therapy (PRCRT) for bulky neuroendocrine tumours.Assessment of predictors of response and long-term survival of patients with neuroendocrine tumour treated with peptide receptor chemoradionuclide therapy (PRCRT).Monitoring early responses to irradiation with dual-tracer micro-PET in dual-tumor bearing mice.Phase II trial evaluating the feasibility of interdigitating folfox with chemoradiotherapy in locally advanced and metastatic rectal cancer.From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.Update on clinical radiobiologyOptimum lean body formulation for correction of standardized uptake value in PET imagingApplication of FDG-PET/CT in Radiation Oncology.FLT PET-CT in evaluation of treatment response.The Advantages and Challenges of Using FDG PET/CT for Response Assessment in Melanoma in the Era of Targeted Agents and Immunotherapy.Advancing molecular imaging: a chairman's perspective on how radiology can meet the challenge.The engagement of FDG PET/CT image quality and harmonized quantification: from competitive to complementary.Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysis.FOLFOX and intensified split-course chemoradiation as initial treatment for rectal cancer with synchronous metastases.Gene therapy with HSV1-sr39TK/GCV exhibits a stronger therapeutic efficacy than HSV1-TK/GCV in rat C6 glioma cells.FDG PET/CT predictive role in follicular lymphoma.
P2860
Q26851368-78FE40F7-C171-4C80-AAA2-5D3E7432622AQ28066962-ABCE12B1-79B3-4CD8-A53D-EBEBCF73DC76Q33435622-F67C76EB-CD23-42AC-907D-D4A00786C076Q34157391-691C9C2B-0AAF-4B62-B686-8660CA135AC7Q34333124-1F015A86-673F-4C83-9A92-1AB7BD2A96E6Q34499632-FCA7CD59-E27A-4A63-A373-C0B8D9CCA53CQ34978457-E10D81E9-E209-4FD7-B2F9-189B0E483BE1Q34991321-4009CF03-75DA-4534-A8AE-ADE549255C69Q35111964-DFD82BF1-77AC-4748-AA96-875F24F13296Q36756445-7640A144-D16D-4613-8CEF-EE64E1B6251EQ38206772-F4E08330-CAF3-4B21-9815-4D7D2B84D10BQ39227781-EDF4CA79-80F3-4D9D-A17A-58373E222B4CQ39842000-B5A766B3-C361-4125-8191-4C60315838EAQ44453305-887F88B5-C1E1-4D43-B192-26EC33EC04ACQ50143284-335ECA3C-1C7F-4281-90F2-78116CB07D5FQ50673731-7BBB9D92-2206-4EDD-AA1C-16D39A630C02Q51467919-D978007E-6A1F-4320-B977-3F53029B7D87Q53135049-5131E1FC-A18B-4736-A8B1-2A00E9B68CF7
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The role of PET in monitoring therapy.
@ast
The role of PET in monitoring therapy.
@en
type
label
The role of PET in monitoring therapy.
@ast
The role of PET in monitoring therapy.
@en
prefLabel
The role of PET in monitoring therapy.
@ast
The role of PET in monitoring therapy.
@en
P2860
P1433
P1476
The role of PET in monitoring therapy.
@en
P2860
P356
10.1102/1470-7330.2005.0006
P577
2005-06-21T00:00:00Z